A cocktail of AI-designed bacteriophages successfully killed E coli bugs resistant to natural viruses in lab tests. This milestone offers a new path for treating persistent infections. However, the ability to engineer viral structures raises urgent biosecurity risks. Practitioners must now balance medical breakthroughs against the danger of synthetic pathogen creation.